1Department of Clinical Neurosciences, Centre Hospitalier Universitaire Vaudois (CHUV), Université de Lausanne, Lausanne, Switzerland.
2Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois, Université de Lausanne, Lausanne, Switzerland.
*See also p. 1144.
Mr. Marchi and Dr. Novy contributed to study concept and design, acquisition of data, analysis and interpretation of data, and drafting/revising the article for content, including medical writing for content. Dr. Faouzi contributed to analysis and interpretation of data, drafting/revising the article for content, including medical writing for content, and statistical analysis. Mrs. Stähli contributed to acquisition of data and drafting/revising the article for content, including medical writing for content. Dr. Burnand contributed to study concept and design, analysis and interpretation of data, drafting/revising the article for content, including medical writing for content, and study supervision. Dr. Rossetti contributed to study concept and design, acquisition of data, analysis and interpretation of data, drafting/revising the article for content, including medical writing for content, statistical analysis, and study supervision and coordination.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website (http://journals.lww.com/ccmjournal).
Dr. Rossetti serves in the editorial boards of Epilepsia and European Neurology, receives research support from the Swiss National Scientific Fund (CR32I3_143780), and received research support from Sage therapeutics, EISAI, and UCB Pharma. All research support is not related to this study. The remaining authors have disclosed that they do not have any potential conflicts of interest.
For information regarding this article, E-mail: [email protected]
